Status: Recruiting
Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer
Phase II, Multicenter, Open-label, Randomized Study evaluating neoadjuvant chemotherapy (FOLFOX4) in patients with stage II and III colorectal cancer with standard chemoradiation Defined by Magnetic Resonance Imaging
Participants needed: 250
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Lithuanian University of Health SciencesUpdated: May 18, 2022Locations: 1
Eligibility criteria
diagnosed with rectal adenocarcinoma; [+5]
patients with signs of intestinal obstruction at the start of treatment; [+5]